Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Furosemide × 90 days × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pre-Eclampsia 1 Lymphoma, Follicular 1

Interventions

Prednisone 5 Dexamethasone 5 Specimen Handling 4 Rituximab 4 Cisplatin 4 enzalutamide 3 darolutamide 3 Vincristine 3 Tobacco Use Cessation Devices 3 Magnetic Resonance Spectroscopy 3 Injections 3 Hydromorphone 3 Carboplatin 3 zanubrutinib 2 trametinib 2 ribociclib 2 pirtobrutinib 2 pembrolizumab 2 obinutuzumab 2 gadolinium ethoxybenzyl DTPA 2 enfortumab vedotin 2 dabrafenib 2 Watchful Waiting 2 Thalidomide 2 Standard of Care 2 Propofol 2 Paclitaxel 2 Oxaliplatin 2 Observation 2 Methotrexate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07167862 2026-01-23

PPPOCUS

University of California, Irvine

Phase 4 Not yet recruiting

Lymphoma, Follicular, Pre-Eclampsia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡